Article
FDA Approval for Senseonics' Glucose Monitor Could Double the Stock Price
Rating:
0.0
Views:
67
Likes:
1
Library:
1
SENS stock should follow a similar trajectory to DexCom, and if it does, it will likely explode in price following FDA approval.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value